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use#LAASynthetic biology is an emerging field of interdisciplinary 
research  that  seeks  to  transform  our  ability  to  probe, 
manipulate,  and  interface  with  living  systems  by 
combining  the  knowledge  and  techniques  of  biology, 
chemistry, computer science, and engineering. Its main 
aim  is  to  increase  the  ease  and  efficiency  with  which 
biological  systems  can  be  designed,  constructed,  and 
characterized. Core efforts in the field have focused on 
the development of tools to support this goal, including 
new  approaches  to  biological  design  and  fabrication. 
Although  the  first  generation  of  synthetic  systems 
demon  strated  genetic  circuits  that  encode  dynamic 
behavior,  cellular  computational  operations,  and  bio­
logical  communication  channels,  more  recent  research 
has focused on implementing synthetic biological devices 
and  systems  in  diverse  applications,  including  disease 
therapy, environmental remediation, and biosynthesis of 
commodity  chemicals.  As  the  field  matures,  synthetic 
biology  is  advancing  biological  frontiers  by  expanding 
biomanufacturing  capabilities,  developing  next­genera­
tion therapeutic approaches, and providing new insights 
into  natural  biological  systems.  Here,  we  review  the 
theoretical foundations, diverse tool kits, and engineered 
systems that have emerged from synthetic biology and 
discuss current as well as potential future applications, 
which include in­depth studies of basic biology (such as 
understanding  endogenous  signaling  pathways  and 
feedback circuits) and new frontiers in health and medi­
cine (such as identification of diseased cells and targeted 
therapeutics).
Conceptual frameworks for biological design
A central aim of synthetic biology is to increase the ease 
and  efficiency  with  which  biological  systems  can  be 
designed, constructed, and characterized. Although the 
manipulation  of  biological  organisms  and  molecular 
pathways  long  preceded  the  emergence  of  synthetic 
biology, the engineering of biological systems has been a 
largely ad hoc exercise. A main reason is that biology is 
inherently diverse, mutable, and context specific. Natural 
biological substrates, including genetic elements such as 
promoters and genes, do not always behave predictably 
when implemented in different combinations, and details 
such as how individual parts are physically connected can 
vary widely across different construction methods. As a 
result, the components designed and assembled for one 
biological system often cannot be predictably reused in 
another system. Synthetic biology seeks to address this 
challenge  by  implementing  a  more  ‘engineering­ready’ 
conceptual  framework  that  emphasizes  the  need  to 
generate  and  report  biological  constructs  in  a  manner 
that is conducive to their understanding and utilization 
by a broad community of researchers.
The application of engineering tools such as abstrac­
tion, decoupling, and standardization was proposed early 
in  the  emergence  of  synthetic  biology  to  support  the 
efficiency  and  scaling  of  the  biological  system  design 
process  [1].  An  abstraction  hierarchy  that  dissects  the 
engineering  process  into  several  design  levels  ­  DNA, 
parts, devices, and systems ­ provides synthetic biologists 
with a means to manage complexity and distribute tasks. 
The  design  process  at  each  abstraction  level  can  be 
performed  relatively  independently  of  the  other  levels, 
and detailed information critical to one abstraction level 
need only be considered by designers operating at that 
level. This division of labor reduces the amount of infor­
ma  tion that each designer must be expert in to success­
fully design a part, device, or system.
Decoupling  refers  to  the  strategy  of  partitioning  a 
complicated  problem  into  simpler  tasks  that  can  be 
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solution. The separation of design and fabrication pro­
cesses is an important example of decoupling supported 
by  advances  in  design  tools  and  fabrication  platforms. 
The  increasing  efficiency  and  decreasing  cost  of  DNA 
synthesis  allow  synthetic  biologists  to  design  novel 
systems with the confidence that DNA components can 
be readily synthesized by commercial sources. Further­
more, advances in DNA sequencing and synthesis pro­
vide  researchers  with  access  to  biological  components 
encoding functions of interest using sequence informa­
tion  deposited  in  databases,  eliminating  the  need  for 
physical exchange of genetic materials.
Standardization takes several forms, including standardi­
zation  of  physical  assembly,  functional  assembly,  and 
characterization/measurements. Early physical assembly 
standards used biological parts flanked by standardized 
sequences, enabling the interchangeable combination and 
sequential assembly of parts conforming to the specified 
standard through a constant restriction­enzyme/ligation­
mediated cloning strategy [2,3]. Significantly less progress 
has  been  made  in  the  field  on  functional  assembly 
standards, which focus on identifying sequence interfaces 
between two types of parts (for example, ribosome bind­
ing site (RBS) and gene) that allow functional coupling 
and  predictable  activity,  independent  of  the  specific 
sequence  of  each  part.  Several  early  physical­assembly 
strategies  encountered  obstacles  because  the  proposed 
standards impaired the functional assembly of parts by 
requiring  the  insertion  of  standard  sequences  between 
each part. In response, the field is shifting to assembly 
methods  that  do  not  require  restriction­enzyme­
mediated  cloning  [4,5].  Finally,  technical  measurement 
and reporting standards have been proposed to eliminate 
discrepancies  that  result  from  disparate  experimental 
methods  and  to  provide  more  reliable  and  thorough 
characterization data [6]. Standardized characterization 
data  will  support  reliable  sharing  and  reuse  of  parts, 
devices, and systems such that new designs can build on 
the foundation of previous work and move beyond the ad 
hoc model of system development.
Advances in fabrication methods for genetic 
systems
As  synthetic  biological  systems  become  increasingly 
sophisticated, fabrication methods with larger capacities, 
greater  precision,  higher  speed,  and  lower  cost  have 
become increasingly important. Outpacing the develop­
ment of novel parts and devices, a number of ground­
breaking fabrication techniques have been demonstrated 
in recent years, allowing researchers to focus on system 
design while outsourcing or performing system fabrica­
tion with higher efficiencies than was previously possible. 
Advances  in  multiplex  oligonucleotide  synthesis  and 
assembly with microfluidic arrays have allowed cheaper 
de  novo  synthesis  of  gene­length  fragments  [7­9]. 
Further  more, several techniques have been developed for 
the assembly of large DNA fragments, moving the field 
beyond laborious and time­consuming molecular cloning.
For example, transformation­associated recombination 
(TAR)  in  the  yeast  Saccharomyces  cerevisiae  has  been 
used to construct yeast artificial chromosomes encoding 
genes  and  pathways  isolated  from  several  different 
organisms  [4,10].  Yeast  artificial  chromosomes  can  be 
further  modified  with  bacterial  artificial  chromosome 
sequences  to  transfer  the  constructs  to  bacteria  and 
subsequently to mammalian cells [11]. Enzymatic in vitro 
assembly  methods,  such  as  one­step  isothermal  DNA 
assembly, can allow DNA molecules of several hundred 
kilobases  to  be  assembled  without  restriction­enzyme­
mediated digestion [5,12]. A combination of in vitro and 
TAR­based assembly methods was used to assemble and 
clone the first bacterial genome from chemically syn  the­
sized oligonucleotides [13]. However, large sets of parts 
encoding  similar  functions  with  distinct  sequences  are 
needed to avoid undesired recombination events between 
components that share similar sequences when assemb­
ling  large  genetic  systems  with  recombination­based 
strategies.
In addition to DNA synthesis and assembly, methods 
have  been  developed  for  high­throughput  genome 
modification. Multiplex automated genome engineering 
(MAGE) uses the bacteriophage λ­Red single­stranded­
DNA­binding protein β to achieve allelic replacement in 
Escherichia coli. This process can greatly accelerate the 
optimization of biological systems and metabolic path­
ways, provided that the target genes are known and that 
an efficient screening method is in place to identify the 
desired  variants  within  the  diverse  libraries  generated 
[14]. An alternative method termed trackable multiplex 
recombineering (TRMR) has been developed to support 
applications in which a priori knowledge of which target 
gene  to  modify  is  lacking,  enabling  rapid  mapping  of 
genes and quantification of population dynamics [15]. A 
complementary technology called hierarchical conjuga­
tive  assembly  genome  engineering  (CAGE),  which  has 
been used to combine portions of a genome that have 
been  modified  by  MAGE,  was  also  recently  described 
[16]. Although genome modification has been reported 
in yeast [17], most high­throughput methods have been 
limited to demonstrations in E. coli and the extension of 
these  technologies  to  mammalian  cells  remains  an 
impor  tant challenge.
Constructing the toolbox: synthetic biological 
parts and devices
Over the past decade, the synthetic biology community 
has built a large collection of biological parts and devices 
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the  development  of  control  devices  that  alter  protein 
levels in response to prescribed input signals, supporting 
the ability to reprogram cellular behavior. Most systems 
demonstrated  so  far  use  transcription­based  control, 
incorporating constitutive and inducible promoters from 
a  small  set  of  well­characterized  parts,  such  as  the 
tetracycline­ and isopropyl­β­d­thio­galactoside (IPTG)­
inducible  promoters.  However,  inadequacies  in  these 
often­used  promoters,  including  inducer  toxicity  and 
limited selection of input choices and response profiles, 
have motivated the development of libraries of consti  tu­
tive  promoters  with  varying  strengths  [19,20]  and  the 
generation  of  new  inducible  promoters  respon  sive  to 
small molecules [21], gaseous acetaldehyde [22], and light 
[23].  The  expanding  collection  of  promoter  parts 
increases the range of stimuli and expression levels that 
can be achieved, providing greater flexibility in control­
ling the behavior of biological systems.
As the diversity of gene regulatory processes in natural 
biological systems comes to light, efforts have also been 
directed to developing control devices that act through 
posttranscriptional and posttranslational mechanisms. In 
addition  to  parts  such  as  degradation  tags  [24,25]  and 
split inteins [26,27], non­coding regulatory RNAs have 
been used to construct a number of control devices [28]. 
In one example, microbial gene expression was regulated 
by engineered RNA­responsive regulators (termed ‘ribo­
regulators’) that modulate translation initiation by either 
obstructing  or  releasing  the  RBS  of  a  target  gene  in 
response to the presence of a separately transcribed RNA 
sequence [29]. Researchers have demonstrated the utility 
of riboregulators in a variety of applications, including 
protein  localization  studies,  perturbation  of  stress 
response networks, and programmable cell killing [30]. 
RNA­based  devices  responsive  to  small­molecule  and 
protein  inputs  have  also  been  demonstrated,  exerting 
control  over  both  transgenic  and  endogenous  protein 
expres  sion  in  bacteria,  yeast,  and  mammalian  cells 
[31­33],  leading  to  applications  ranging  from  bacteria­
mediated detection and breakdown of pesticides [34] to 
disease­marker  detection  and  cell­fate  regulation  in 
mam  malian  cells  [35].  The  unique  properties  of  RNA­
based control devices ­ including ease of design and con­
struction, small genetic footprint, high energy efficiency, 
fast regulatory time scales, and the ability to tailor input 
responsiveness  and  regulatory  stringency  ­  have  made 
RNA  a  versatile  substrate  for  designing  programmable 
control systems.
In  addition  to  controlling  protein  levels,  synthetic 
biologists have developed tools to modulate the spatial 
organization of protein molecules inside cells, resulting 
in  new  strategies  for  regulating  or  rewiring  cellular 
activities encoded in metabolic and signaling pathways 
[36]. In one example, researchers constructed synthetic 
feedback  loops  within  the  yeast  mating  mitogen­
activated  protein  (MAP)  kinase  pathway  by  recruiting 
modulator proteins to the pathway scaffold protein Ste5 
through fusing leucine zipper domains to each compo­
nent,  and  demonstrated  circuits  with  pulse  generator, 
accelerator,  delay,  and  ultrasensitive  switch  functions 
[37,38]. In another example, synthetic protein scaffolds 
that spatially recruit metabolic enzymes were imple  men­
ted in E. coli, enabling the stoichiometric optimiza  tion of 
three mevalonate biosynthetic enzymes and achieving a 
77­fold increase in product titer while avoiding cellular 
toxicity caused by the accumulation of a pathway inter­
mediate [39]. As an alternative to protein­based scaffolds, 
rationally  designed  RNA  strands  have  recently  been 
shown  to  assemble  into  higher­order  structures, 
Table 1. The synthetic biology toolbox: common components used in synthetic biological systems
	 Component	 Function
Transcriptional  Constitutive promoter libraries [19,20]  Provide continuously ON gene expression at pre-determined levels
  Inducible promoters (for example, responsive to tetracycline,   Provide conditional and, in certain cases, titratable gene expression 
  IPTG, gaseous acetaldehyde [22], or light [23])  in response to inducer signal
Posttranscriptional  Non-coding regulatory RNAs [28] (such as riboregulators   Control protein production levels by regulating mRNA stability or
  [29,30], ribozyme switches [31,51], and RNAi switches [32,33])  translation initiation in response to molecular input
  Alternative splicing modulators [35]  Control protein production levels or protein activity by regulating  
    alternative splicing of mRNA in response to molecular input
  RNase substrate libraries [80]  Control protein levels through tunable hairpin elements that direct  
    transcript cleavage
Posttranslational  Degradation tags [24,25]  Modulate protein levels by shortening protein half-lives
  Split inteins [26,27]  Provide biosensing and modulate protein activity by conditionally  
    splicing inactive protein fragments together into functional wholes
Structural  Protein [36-39], RNA [40], and DNA [93] scaffolds  Regulate signaling and metabolic pathway flux by controlling the 
    localization and stoichiometry of pathway components and  
    intermediate products
IPTG, isopropyl-β-d-thio-galactoside; RNAi, RNA interference.
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[40].  An  RNA  scaffold  was  applied  to  a  two­enzyme 
hydrogen  biosynthesis  pathway  and  shown  to  increase 
hydrogen production by up to 48­fold compared with an 
un  scaff  olded system [40]. These examples highlight the 
utility of spatial engineering in enhancing and modifying 
bio  logical pathways.
Synthetic gene circuits
One of the hallmarks of synthetic biology has been the 
drive to engineer biological systems from the bottom up. 
Model­driven  design  of  synthetic  gene  circuits  has 
demon  strated  the  ability  to  build  circuits  of  specified 
function [41­43]; differences between models and realized 
circuits have illuminated important and unique aspects 
of  biological  system  behavior,  such  as  the  effects  of 
degradation processes, cooperativity, and noise [44­46]. 
In  addition  to  inspiring  the  design  of  more  robustly 
operating systems, the insights gained through synthetic 
approaches  have  contributed  to  our  understanding  of 
natural biological systems [47].
Genetic	circuits	encoding	dynamic	behaviors
The construction of two genetic circuits encoding dynamic 
behavior, the repressilator [44] and the toggle switch [48], 
marked  two  early  efforts  in  genetic  circuit  design  in 
synthetic biology. The repressilator, a three­ring oscillator 
built  from  a  loop  of  three  repressor­promoter  pairs, 
demonstrated  that  an  oscillatory  response  could  be 
generated  from  biological  parts  not  found  in  natural 
biological  oscillators.  However,  the  synthetic  oscillator 
showed fluctuations and heterogeneity not observed in 
natural circadian oscillators, which generally use inter­
linked positive and negative feedback loops [45]. Subse­
quent generations of oscillators have interlinked positive 
and negative transcriptional feedback loops of different 
strengths to drive more robust oscillatory dynamics with 
tunable  periods  and  amplitudes  in  bacterial  [42]  and 
mammalian cells [49] (Figure 1a). In the post­genomics 
era, the importance of precise timing and coordination of 
gene  expression  in  regulating  systems­level  behavior  is 
increasingly  appreciated.  Well­defined,  synthetic  gene 
circuits that control the temporal profile of gene expres­
sion  can  elucidate  the  contributions  of  expression 
dynamics to natural time­dependent processes, such as 
cell signaling, cell­fate determination, and development. 
Synthetic gene circuits also offer the potential to develop 
genetically  encoded  strategies  for  intervening  and 
controlling these natural processes.
Encoding	cellular	logic	and	computing	functions
Genetic circuits that perform computations and logical 
evaluations of cellular information provide the ability to 
assess  intracellular  states  and  environmental  signals. 
They transmit this information into changes in cellular 
function, such as production of easily assayed readouts, 
activation of metabolic pathways, or initiation of cell­fate 
decisions. Towards this goal, genetic circuits and devices 
capable of performing logical evaluations have been built 
to  detect  small  molecules  (using  tandem  promoter 
systems  [50]  and  RNA  devices  [51]),  and  small  RNAs 
such as small interfering (si)RNAs (using tandem RNA 
interference (RNAi) target sites [52]) (Figure 1b). These 
various  schemes  have  demonstrated  the  classic  NOT, 
OR, NOR, and AND gates that are used to build larger 
logic evaluators and computations.
Methods  for  counting  and  maintaining  memory  of 
system  states  will  enable  a  broader  spectrum  of  intra­
cellular computing. A genetic circuit that can count up to 
three exposure events to a small­molecule inducer was 
built in bacteria by nesting polymerase­promoter pairs 
controlled  by  riboregulators  responsive  to  an  inducible 
transactivator  [53].  Although  this  system  captured  brief 
induction pulses, system performance was highly depen­
dent on pulse duration and frequency. The incorporation 
of genetic memory offers an alternative strategy to increase 
the robustness of counting events over longer time frames. 
A three­event counter circuit was demon  strated by using 
DNA recombinase­based cascades that record each event 
as a permanent change to the DNA, where the output of 
each recombinase event would ‘prime’ the next promoter­
recombinase pair in the circuit [53]. Synthetic networks of 
feedback loops have been built as memory circuits that 
lock a system in one state through sustained production of 
proteins following a transient signal that initiates the state. 
For example, toggle switches engineered to show bistability 
in bacteria [48] and mammalian cells [54] use architectures 
of mutually inhibitory feedback loops to achieve reversible 
memory of small­molecule pulses. As another example, a 
positive  feedback  loop  built  from  a  synthetic  trans­
criptional  activator  cascade  demonstrated  heritable 
memory over many generations in yeast [55].
One recurrent limitation in adapting biological systems 
to perform computation through the rules of binary logic 
is the analog nature of the responses. In particular, gene 
expression  leakage  in  the  OFF  state  can  contribute  to 
improper  input  processing  and  high  basal  output, 
diminishing  an  evaluator’s  signal­to­noise  ratio 
[48,53,55]. In addition, control of highly lethal proteins 
and  proteins  that  mediate  irreversible  genetic  changes 
requires  stringent  OFF  states.  To  address  this  issue, 
researchers  have  layered  transcriptional  and  post­
transcriptional control elements within genetic circuits 
to provide strategies for achieving stringent regulation of 
transgenes in mammalian [56,57] and bacterial cells [30]. 
In one example, an inducible promoter was layered with 
repressible  expression  of  a  small  hairpin  (sh)RNA  to 
achieve undetectable expression levels of the highly lethal 
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cell death only in the ON state [56]. Although tight OFF 
states  are  desirable  for  binary  computing,  biological 
computing  necessarily  exploits  the  analog  and  tunable 
nature  of  gene  expression.  Connecting  logical  circuit 
outputs to changes in cellular state requires the ability to 
Figure	1.	Synthetic	circuits	that	perform	diverse	functions	can	be	coupled	to	achieve	higher-order	responses. (a)	Interlinked positive 
and negative feedback loops of different strengths drive an oscillatory response. Arabinose-responsive transcriptional activator (AraC) expression 
positively modulates gene expression and results in a positive feedback loop, whereas the isopropyl-β-d-thio-galactoside (IPTG)-responsive inhibitor 
of the lac promoter (LacI) inhibits expression and generates a negative feedback loop. The small-molecule inducers arabinose and IPTG modulate 
the strength of these feedback loops [42]. GFP, green fluorescent protein. (b) A mammalian AND gate composed of RNA interference (RNAi) target 
sites evaluates small interfering (si)RNA inputs. Unique RNAi target sites are placed in the 3’ UTR of two lacI genes, and LacI regulates the expression 
of a fluorescent reporter, resulting in an AND logic evaluator for the siRNA inputs m1 and m2 [52]. YFP, yellow fluorescent protein. (c) Quorum-
sensing circuitry allows population control. Cell density is broadcast by the diffusible small molecule acyl-homoserine lactone (AHL), which is 
synthesized by the enzyme LuxI (X). As cell density and AHL concentration increase, LuxR (R), a transcriptional regulator, binds AHL and initiates 
expression of a ‘killer’ gene (encoding CcdB, a lethal protein that targets the DNA gyrase complex), ultimately reducing the steady-state cell density 
[58]. (d) Interlinking positive and negative feedback loops with communication circuitry enables oscillation synchronization across a population 
of cells. Expression of R positively regulates expression of X, R, GFP, and AiiA (A), an enzyme that degrades AHL. As A increases in concentration, 
it degrades AHL and negatively modulates protein expression levels [62]. (e) Combining logic processing with communication circuitry enables 
a synthetic biological edge detection system. The expression of X and the transcriptional repressor cI (Y) is turned ON in cells in the dark region, 
where Y represses the expression of the pigment-producing protein (pigment: β-galactosidase, an enzyme that cleaves a substrate to produce 
a black pigment). However, diffusion of AHL synthesized by cells in the dark region activates R in cells at the edge of the light region (where Y is 
turned OFF), thus turning ON expression of pigment only in cells along this edge [63].
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behavior  diverges  and  tune  the  output  to  cross  that 
threshold when triggered. Combining the computational 
ability of logical evaluators with improved strategies for 
leakage minimization and output tuning should enable 
more  robust  computing.  These  tools  can  expand  our 
ability  to  detect  and  treat  diseases  by  increasing  diag­
nostic certainty and improving precision in gene expres­
sion,  and  can  also  be  used  to  probe  previously 
inaccessible information sets, such as the temporal and 
spatial profiles of particular developmental genes, which 
will inform our fundamental understanding of biology.
Communication	circuits	supporting	more	complex	
behaviors
Communication  systems  are  required  to  coordinate 
events and tasks between different cells in a population. 
Synthetic communication circuits have been engineered 
in  bacteria  using  various  bacterial  quorum­sensing 
systems. In these systems, a lactone signal is broadcast 
with increasing strength as cell density increases. At a 
given  threshold  level,  lactone  binds  and  activates  a 
transcriptional regulator, upregulating the expression of a 
target  gene.  Broadcasting  and  receiving  can  be  incor­
porated  within  a  single  cell  population  or  distributed 
between ‘sender’ and ‘receiver’ cells. Incorporating both 
functions in a single population programmed to regulate 
a killer gene resulted in population control and demon­
strated how population heterogeneity can be exploited to 
achieve  a  robust  population  response  [58]  (Figure  1c). 
Segregating  tasks  and  localizing  the  sender  population 
established  a  radial  gradient  of  signaling  molecules. 
Coupling  the  quorum­sensing  circuitry  to  a  band­pass 
circuit, which detects a specified range of input concen­
trations, achieved formation of various radial patterns in 
the receiver cells [59]. In addition, connecting bacterial 
quorum systems to synthetic circuits has demonstrated 
dual­population  consensus  response  and  symbiosis  in 
biofilms  [60,61]  and  synchronized  genetic  clocks  [62] 
(Figure  1d).  Finally,  coupling  a  light­responsive  device 
[23] to logic­processing circuitry and a communication 
module  resulted  in  a  biological  edge  detector  [63] 
(Figure 1e). These examples demonstrate how synthetic 
circuits  can  distribute  and  coordinate  computational 
tasks  across  a  population  of  cells  to  achieve  complex 
responses similar to what is observed in natural pattern 
formation and development.
Beyond  bacterial  systems,  mammalian  receiver  cells 
have  been  engineered  to  respond  to  volatile  chemical 
signals  [64]  and  metabolic  conditions  [65]  using  engi­
neered  synthetic  promoters.  These  receivers  can  poten­
tially be paired with various processing circuits and sender 
cells to generate synthetic hormone­signaling systems and 
synthetic ecosystems. The eventual coupling of metabolic 
functions  and  cell­fate  circuitry  to  synthetic  hormone­
signaling  systems  will  enable  spatial  patterning  of  cell 
differ  entiation and timing of coordinated cellular responses, 
a requisite for complex tissue formation and function.
Moving towards real-world applications
Despite  remarkable  advances  in  the  design  and  con­
struction  of  increasingly  sophisticated  genetic  circuits 
over the past decade, the transition of these systems to 
real­world  applications  has  been  constrained  by  the 
limited availability of devices that can connect synthetic 
circuitry  with  information  in  living  systems.  However, 
synthetic biologists are developing new ways to connect 
natural and engineered systems. For example, exploiting 
existing  connections  between  synthetic  circuitry  and 
intra  cellular  information,  researchers  have  used  the 
natural correlation between DNA damage and proteolysis 
of the ON state inhibitor λ cI in a genetic toggle switch to 
record  transiently  induced  DNA  damage  through  the 
formation  of  a  biofilm  [66].  Taking  another  approach, 
researchers  have  constructed  synthetic  sensor  devices 
from  natural  components,  such  as  promoter­repressor 
pairs  [67,68],  signaling  pathway  components  [69],  and 
small RNAs and their target sites [52,57], to extract infor­
mation from biological systems. As the range of sensor 
devices, processing circuitry, and output modules expands, 
synthetic biology is poised to address a broad scope of 
biological, medical, and biotechnological challenges.
Understanding	biology	by	building
The ability to construct synthetic genetic circuits from 
the  bottom  up  has  enabled  researchers  to  approach 
questions in basic biology from a new angle. Instead of 
perturbing natural pathways or model systems, biological 
systems can be probed by constructing artificial circuits 
and examining their behavior and interactions with endo­
genous machinery [70]. For example, in one investigation 
into  why  a  particular  circuit  architecture  was  selected 
over others that produced similar dynamics, researchers 
compared  the  native  Bacillus  subtilis  circuit  that 
regulates differentiation into the competence state (when 
cells can take up DNA from the environment) with an 
engineered circuit [71] (Figure 2a). Modeling and empi­
rical  results  both  indicated  that,  despite  generating 
excitable dynamics with similar shapes and frequency to 
those of the native competence circuit, the engineered 
circuit  achieved  greater  precision  in  the  duration  of 
competence. It was further demonstrated that the greater 
variability in the native circuit conferred an advantage in 
the  form  of  more  consistent  transformation  efficiency 
over a large range of extracellular DNA concentrations, 
highlighting the effective exploitation of noise in natural 
circuits  [71].  Additional  synthetic  circuits  have  been 
constructed  to  study  the  modularity  and  plasticity  of 
Chen et al. Genome Biology 2012, 13:240 
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Page 6 of 10MAP kinases [72,73] and the interaction between Notch 
and Delta critical for cell patterning during development 
[74],  among  others  [70],  illustrating  the  utility  of  syn­
thetic biology in expanding our fundamental understand­
ing of biology.
Expanding	biomanufacturing	capabilities
Biomanufacturing  is  one  of  the  more  compelling  and 
immediate applications of biotechnology that promises 
sustainable  synthesis  strategies  for  alternative  energy 
sources, commodity chemicals, and high­value specialty 
chemicals such as therapeutic drugs. A major challenge 
of biosynthetic pathway engineering lies in balancing the 
levels and activities of the many heterologous pathway 
enzymes to achieve optimized productivity and yield of 
desired compounds in the microbial host. Synthetic bio­
logy is transforming biosynthesis capabilities by provid­
ing  new  tools  that  support  pathway  construction  and 
Figure	2.	Synthetic	biological	circuits	can	aid	in	understanding	of	biology,	improve	biomanufacturing	productivity,	and	enable	disease-
targeted	therapy. (a) The native circuit regulating competence in B. subtilis was compared with a synthetic circuit with similar dynamics to 
reveal architecture-specific variability in the duration of competence and consequent differences in the consistency of transformation efficiency 
over large ranges of DNA concentration [71]. (b) A synthetic protein scaffold was used to increase the biosynthesis of mevalonate from acetyl-
CoA in E. coli. The scaffold consists of three protein-protein interaction domains (GBD, the GTPase binding domain from the actin polymerization 
switch N-WASP; SH3, the Src homology 3 domain from the adaptor protein CRK; and PDZ, the PSD95/DlgA/Zo-1 domain from the adaptor 
protein syntrophin) in various copy numbers connected by glycine-serine linkers. Pathway enzymes (AtoB, acetoacetyl-CoA thiolase; HMGS, 
hydroxymethylglutaryl-CoA synthase; HMGR, hydroxymethylglutaryl-CoA reductase) were each fused to the ligands of one interaction domain and 
recruited to the protein scaffold [39]. PTET, tetracycline-inducible promoter; PBAD, arabinose-inducible promoter.	(c) A targeted therapeutic circuit was 
constructed by inserting an RNA aptamer near an alternatively spliced exon harboring a stop codon in a three-exon, two-intron minigene fused 
to herpes simplex virus thymidine kinase (HSV-TK). Binding of a disease marker protein to the aptamer results in exclusion of the alternative exon, 
expression of a suicide gene, and killing of diseased cells [35]. PCMV, cytomegalovirus promoter.
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Page 7 of 10optimization.  For  example,  researchers  have  recently 
combined  TAR­based  assembly  strategies  with  sets  of 
biosynthetic  pathway  parts  (including  enzyme  coding 
regions, promoters, and terminators) to demonstrate one­
step,  whole­pathway  assembly  for  a  variety  of  natural­
product pathways [75­77]. In another example, combina­
torial  libraries  of  tunable  intergenic  regions  (TIGRs) 
harboring a number of RNA regulatory elements, includ­
ing  terminators,  RNase  cleavage  sites,  and  stabilizing 
hairpins,  were  assembled  in  the  non­coding  regions 
between three heterologous enzymes in the mevalonate 
biosynthetic  pathway  expressed  from  a  polycistronic 
transcript in E. coli. Researchers screened library variants 
for the TIGR sequences that resulted in optimal relative 
expression levels of each enzyme to increase mevalonate 
production;  the  best  mevalonate  producers  decreased 
accumulation  of  a  toxic  intermediate  and  increased 
growth rate [78]. Libraries of modular control elements, 
including promoters and RNA regulatory elements, that 
have broad ranges of predictable activities have also been 
generated [19,79]. Recently, a library of RNase cleavage 
elements was used in yeast to titrate a key enzyme and 
thus  flux  through  the  endogenous  ergosterol  pathway, 
which competes with synthetic terpenoid pathways for 
the  common  precursor  farnesyl  pyrophosphate  [80]. 
Finally,  several  new  tools  supporting  colocalization  of 
heterologous enzymes, such as protein­ and RNA­based 
scaffolds, are being used to develop pathway optimization 
strategies based on spatial engineering [39,40] (Figure 2b).
Advancing	next-generation	therapeutics	and	diagnostics
By developing new strategies to interface with and mani­
pu  late natural biological systems, synthetic biology holds 
exciting promise in developing new therapeutic approaches. 
For instance, synthetic biologists are develop  ing genetic 
circuits that link therapeutic activities to the detection of 
molecular disease signals to develop targeted thera  peu­
tics with increased efficacy and safety. In one example, a 
layered  microRNA  (miRNA)­  and  transcription­factor­
based  logic  circuit  was  used  to  distinguish  a  cervical 
cancer cell line (HeLa) from other cell lines based on the 
detection  of  a  unique  miRNA  profile  [57].  Positive 
identification of HeLa cells through this logic circuit was 
subsequently  linked  to  either  expression  of  a  reporter 
protein, as a model diagnostic device, or expression of a 
protein  that  led  to  cell  death  as  a  model  therapeutic 
device.  In  another  example,  to  restrict  cell  death  to 
diseased cells showing hyperactive signaling, researchers 
developed  protein­responsive  RNA  devices  that  could 
detect increased signaling through the NF­κB and Wnt 
pathways and transmit this information into changes in 
the expression of a clinically relevant suicide gene that 
sensitizes  cells  to  an  apoptosis­inducing  prodrug  [35] 
(Figure 2c). These types of autonomous sense­and­control 
circuits  offer  potential  applications  in  the  long­term 
surveillance and intervention of chronic diseases, such as 
gout  and  diabetes  [68,81].  Circuits  currently  under 
develop  ment  that  link  genetic  targets  to  clinician­
modulated external inputs will provide an unprecedented 
level  of  temporal  and  spatial  control  over  complex 
therapeutic  activities.  For  example,  systems  have  been 
described that support light­modulated glucose homeo­
stasis [82] and drug­modulated control over in vivo gene 
expression [83] and T­cell proliferation [84].
Where will synthetic biology take us?
The  biological  parts,  genetic  circuits,  and  fabrication 
techniques that have been developed and continue to be 
improved on offer exciting potential in diverse applica­
tions,  from  environmental  engineering  to  regenerative 
medicine. Synthetic biological systems capable of detect­
ing,  reporting,  and/or  removing  hazardous  substances 
have been reported [85­88], and their implementation in 
robust host organisms suitable for environmental release 
will provide a new paradigm for environmental remedia­
tion. In the area of health and medicine, synthetic inter­
cellular  communication  systems  that  regulate  spatial 
patterning, timing of coordinated cellular responses, and 
tissue homeostasis have the potential to make significant 
contributions  to  tissue  engineering.  Furthermore, 
synthetic  control  circuitry  may  reduce  the  inherent 
tumori  genicity  of  stem  cells  [89]  and  improve  the 
efficiency  of  induced  pluripotent  stem  cell  reprogram­
ming [90]. Novel genetic circuits capable of guiding the 
ex vivo construction of complex tissues may be built in 
the foreseeable future as researchers continue to unravel 
the systems biology behind cell­fate decisions [91,92].
Efforts in synthetic biology so far have covered a wide 
range of topics spanning broad conceptual frameworks 
and specific circuit designs, and the future direction of 
synthetic biology is by no means limited to the few areas 
highlighted here. However, a unifying driving force in the 
field  has  been  the  desire  to  efficiently  build  biological 
systems,  whether  to  improve  our  fundamental  under­
stand  ing of biology or to provide solutions for pressing 
global challenges. By developing conceptual frameworks 
and technical tools for the design, construction, and charac­
terization of novel biological systems that can perform 
autonomous functions and interact with natural biologi­
cal systems, synthetic biology is poised to trans  form our 
ability to probe, understand, and manipulate biology.
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